Cases
Cases: Hospira Healthcare Corporation v Janssen Inc
Counsel for the Kennedy Trust
Janssen in a patent impeachment
infringement action related to Remicade (infliximab), a biologic treatment for rheumatoid arthritis. This is the first patent infringement action in Canada relating to a Subsequent Entry Biologic (a generic version of a biologic drug, also referred to as a biosimilar).
Andrew Skodyn & Melanie Baird April 3, 2018
United American Corp et al v Instagram
Counsel to Instagram in a patent infringement action relating to methods for the sharing of content on social media.
Melanie Baird, Andrew Skodyn & Veronica C. Tsou April 2, 2018
United American Corp et al v Facebook
Counsel to Facebook in a patent infringement action relating to methods for the sharing of content on social media.
Melanie Baird, Andrew Skodyn & Veronica C. Tsou April 2, 2018
Janssen Inc v Apotex Inc
Counsel to Janssen in proceedings pursuant to the PM(NOC) Regulations relating to Prezista (darunavir), an antiretroviral medication.
Andrew Skodyn, Melanie Baird, Veronica C. Tsou & Naomi Metcalfe January 8, 2018
Valeant Canada LP v Ranbaxy Pharmaceuticals Canada Inc.
Counsel to Valeant in proceedings pursuant to the PM(NOC) Regulations relating to Wellbutrin XL (bupropion hydrochloride), a medication used to treat depression.
Andrew Skodyn, Sana Halwani, Melanie Baird & Laurel D. Hogg July 7, 2017
Purdue Canada v Collegium Pharmaceutical Inc.
Counsel to Collegium Pharmaceutical Inc. against Purdue Pharma in an application under the Patented Medicines (Notice of Compliance) Regulations, as well as a patent infringement action, involving the medicine XTAMPZA ER (a tamper-resistant oxycodone product used in pain management).
James S.S. Holtom, Andrew Skodyn, Sana Halwani, Melanie Baird, Laurel D. Hogg & Naomi Metcalfe June 28, 2017
Pharmascience Inc. v Valeant Canada LP
Counsel to Valeant in an action for damages under section 8 of the PM(NOC) Regulations relating to Sublinox (zolpidem), a medication used to treat insomnia.
Andrew Skodyn, Sana Halwani, Melanie Baird & Veronica C. Tsou June 13, 2017
Teva Canada Limited v Janssen Inc
Counsel to Janssen in a patent impeachment
infringement action relating to Velcade (bortezomib), a product used to treat certain cancers.
Andrew Skodyn & Melanie Baird June 12, 2017
Valeant Canada LP v Generic Partners Canada Inc.
Counsel to Valeant in proceedings pursuant to the PM(NOC) Regulations relating to Glumetza (metformin), a medication used to treat type 2 diabetes.
Andrew Skodyn, Melanie Baird, Sana Halwani & Naomi Metcalfe June 9, 2017
Hawk Technology Systems LLC v IBM Canada Limited
Counsel for IBM in a patent infringement action relating to video monitoring technologies.
Andrew Skodyn & Melanie Baird December 20, 2016
Smart Cloud Inc v International Business Machines Corporation
Counsel for IBM in a passing off action relating to IBM's cloud computing services
technologies.
Andrew Skodyn, Melanie Baird, Laurel D. Hogg & Naomi Metcalfe November 24, 2016
Various Law Firms
Insurers
Litigating professional negligence matters as well as negotiating
structuring complex resolutions in the course of litigation.
Melanie Baird October 28, 2016
Venngo Inc v Concierge Connection Inc cob as Perkopolis
Counsel to Venngo in an appeal to the Federal Court of Appeal
a leave to appeal application to the Supreme Court of Canada of a decision relating to trademark infringement
passing off.
Andrew Skodyn, Melanie Baird, James S.S. Holtom & Sana Halwani September 21, 2016
Hospira Healthcare Corporation v The Kennedy Trust
Counsel for the Kennedy Trust in a patent dispute. In the first unanimous five-judge decision of the Federal Court of Appeal, successfully argued that the st
ard of review applicable to the decisions of Prothonotaries should be in accordance with Housen v Nikolaisen, overturning a long line of prior authority.
Andrew Skodyn, Melanie Baird & James S.S. Holtom September 14, 2016
Janssen Inc v Attorney General of Canada
Counsel to Janssen
the Kennedy Trust for Rheumatology Research in a judicial review application relating to the PM(NOC) Regulations
Health Canada's policies regarding Administrative New Drug Submissions.
Andrew Skodyn & Melanie Baird November 18, 2015
Janssen Inc v Celltrion Healthcare Co Ltd
Counsel for Janssen in proceedings under the PM(NOC) Regulations related to Remicade (infliximab), a biologic treatment for rheumatoid arthritis.
Melanie Baird September 22, 2015
Valeant Canada LP v Pharmascience Inc.
Counsel for Valeant in a proceeding pursuant to the PM(NOC) Regulations relating to Sublinox (zolpidem), a medication used to treat insomnia.
Andrew Skodyn, Melanie Baird & James S.S. Holtom July 1, 2015
Valeant Canada LP v Actavis Pharma Company
Counsel for Valeant in a proceeding pursuant to the PM(NOC) Regulations relating to Wellbutrin XL (bupropion), an antidepressant.
Andrew Skodyn & Melanie Baird June 9, 2015
Charette v Trinity Capital Corporation
Counsel to two defendants in a class action brought on behalf of taxpayers who participated in a charitable donation program.
Glenn Smith, Peter Griffin, Rebecca Jones & Melanie Baird April 3, 2013
Tucci v Smart Technologies Inc
Counsel to two defendants in a securities class action alleging prospectus misrepresentation by the issuer, selling shareholders
others. Class definition under section 130 of the Securities Act successfully restricted to purchasers under the prospectus
not secondary market purchasers during the period of distribution.
Peter Griffin & Melanie Baird February 19, 2013
Valeant Canada LP v Cobalt Pharmaceuticals
Counsel for Valeant in a proceeding under the PM(NOC) Regulations relating to a hypertension medicine.
Andrew Skodyn, Melanie Baird & Danielle Glatt September 6, 2012
Janssen Inc v Apotex
Counsel for Janssen in proceedings under the PM(NOC) Regulations relating to Tri-Cyclen Lo (norgestimate), an oral contraceptive.
Melanie Baird September 5, 2012
Janssen Inc v Teva Pharmaceuticals
Counsel for Janssen in proceedings under the PM(NOC) Regulations relating to Tri-Cyclen Lo (norgestimate), an oral contraceptive.
Melanie Baird September 5, 2012
AbbVie Corporation v Janssen Inc
Counsel for Janssen in a patent infringement action relating to Stelara (ustikinumab), a monoclonal antibody product for use in the treatment of psoriasis, among other indications. This was the first patent infringement trial in Canada relating to a biologic drug.
Anne E. Posno, Melanie Baird & J. Gwendolyn Ward December 1, 2011
Aldo Group Inc v Moneris Solutions Corporation
Counsel to Moneris in a contractual dispute. Successfully resisted forum non conveniens motion by MasterCard in first instance
on appeal.
Peter Griffin & Melanie Baird November 1, 2011
Valeant Canada LP v Mylan Pharmaceuticals
Counsel for Valeant in a proceeding pursuant to the PM(NOC) Regulations relating to Wellbutrin XL (bupropion), an antidepressant.
Melanie Baird October 1, 2011
Various Pharmaceutical Companies
Negotiating
structuring settlements
drafting complex settlement agreements
business arrangements in the course of litigation.
Melanie Baird September 1, 2011
The Canadian Copyright Licensing Agency
Counsel to the Canadian Copyright Licensing Agency in connection with numerous proceedings to obtain
enforce judgments for copyright infringement against individual
corporate defendants. (Prior to joining Lenczner Slaght)
Melanie Baird August 1, 2011
Research In Motion Limited
Counsel to RIM in connection with its $200 million acquisition of QNX Software Systems from Harman International Industries, Incorporated. (Prior to joining Lenczner Slaght)
Melanie Baird June 1, 2011
Corel
an Independent Directors' Committee of the Board
Counsel in connection with a US tender offer by controlling shareholder Vector Capital. (Prior to joining Lenczner Slaght)
Melanie Baird May 1, 2011
Research In Motion Limited
Counsel to RIM in connection with its $150 million acquisition of Certicom Corp. (Prior to joining Lenczner Slaght)
Melanie Baird April 1, 2011
The Underwriters
In connection with a $23 million bought deal offering of common shares by COM DEV International Ltd. (Prior to joining Lenczner Slaght)
Melanie Baird March 1, 2011
ProMetic Biosciences, Inc
Successfully defeated technology licensee in connection with the CCAA restructuring of Hemosol Corp. in complex proceedings before the Superior Court of Justice in the Matter of a Plan of Compromise or Arrangement of Hemosol Corp.
Hemosol LP. (Prior to joining Lenczner Slaght)
Melanie Baird February 1, 2011
